ERβ was also found to counter Akt signaling by downregulating the upstream HER2/HER3 receptor dimer and upregulating the tumor suppressor PTEN that is known to inhibit Akt signaling in breast cancer cells [39]. This evidence concerns the gene AKT1 and breast cancer.